The US Securities and Exchange Commission yesterday charged Elizabeth Holmes, the founder and CEO of Theranos, and Ramesh Balwani, its former president, with fraud, as 360Dx reports. The SEC alleges that Holmes and Balwani raised more than $700 million from investors by exaggerating or lying about the capabilities of the company's technology.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An analysis of UK Biobank data finds hemochromatosis to be more prevalent than thought, according to the BBC.

An analysis finds that female biomedical researchers receive fewer prizes than male ones, and when they do win prizes, they are less prestigious.

In Nature this week: improved genomic analysis using a graph genome reference, tumor mutational burden could predict clinical response to immune checkpoint inhibitors, and more.

Federal researchers tell the Los Angeles Times that the shutdown is causing missed research opportunities as they try to keep their experiments going.